The phrase "allows for the dose" is correct and usable in written English.
It can be used in contexts where you are discussing the flexibility or capacity to accommodate a specific dosage of medication or treatment.
Example: "The new medication formulation allows for the dose to be adjusted based on the patient's response."
Alternatives: "permits the dosage" or "facilitates the dose".
In contrast to SAM, PIR allows for the dose-response relationship to be nonlinear, but assumes the relationship is increasing or decreasing as a function of increasing dose, and not the reverse direction.
IMRT allows for the radiation dose to conform more precisely to the three-dimensional shape of the tumor by modulating or controlling the intensity of the radiation beam by computerized treatment planning system calculation and dose delivery through Multileaf Collimator.
This allows for the design of dose-escalation protocols using protons in combination with new biologic therapies and chemotherapy.
That is what allows for the once-a-day dosing.
This trial allows for the assessment of specific doses of the medicine to try to determine the correct dosage, and also, if this child is a good candidate for a Baclofen pump.
Intrathecal drug delivery (ITDD) facilitates the direct administration of drugs at a site of action, which allows for the use of lower doses of the drugs, thereby reducing their side effects while achieving maximum therapeutic benefit.
Dosage adjustments, based on efficacy, tolerability, and/or body weight, were permitted in this trial and allowed for the micafungin dose to be increased to 200 mg daily and the LAmB dose to be increased to 5 mg/kg/day.
Administration of subchronic toxic doses allows for the high probability that the toxic effect will be observable and defined at the structural level.
Even allowing for the normal dose of government spin, it is remarkable that one fourth of the Recovery Act's funds have been committed already and that 70percentt has been earmarked for deployment by the end of September 2010.
Alternatively, the durability of clinical response to golimumab 50 mg may be less than that to golimumab 100 mg in this patient population beyond 24 weeks or it could be that investigator discretion, rather than objective escalation criteria, allowed for the golimumab dose to be escalated despite achievement of an otherwise acceptable response.
